Immunotherapy in China: -Night All-Inclusive Package with Price
What's included in this package
Medical Procedures
- Immunotherapy
- 24-hr nurse services
Duration
Accommodation
Accommodation is not included
Transport
Transfer is not included
Additional information
This treatment uses a PD-1 inhibitor to help the immune system recognize and attack cancer cells. The therapy may be recommended for patients with certain types and stages of cancer, depending on their diagnosis and biomarker results.
The treatment plan is individually selected by the oncologist based on the patient's medical history, previous treatments, and test results.
Package includes:
Oncology consultation
Treatment planning
PD-1 inhibitor therapy
Necessary monitoring during treatment
The treatment plan is individually selected by the oncologist based on the patient's medical history, previous treatments, and test results.
The exact medication, number of treatment cycles, and final cost are determined after medical evaluation.
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Program price
special price valid till November 16, 2026
What's NOT included in this package
Doctor
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
How are we doing?
About the clinic
Immunotherapy at Uni-Asia Cancer Hospital in Chengdu, China, provides a precision-based approach for patients with advanced or recurrent tumors. The hospital specializes in combining immune checkpoint inhibitors with local treatments like ablation and radiotherapy. This strategy helps treat complex cases, including lung cancer with liver metastasis and liver cancer.
Precision Testing and Treatment Selection
Before treatment starts, doctors use biomarker testing to create a personalized plan. They test for Programmed death-ligand 1 (PD-L1) expression and check a driver-gene panel. This panel includes EGFR, ALK, ROS1, BRAF, MET, RET, and KRAS. The results help the medical team choose the most effective immunotherapy drugs for each patient. This precision model targets specific cancer characteristics to improve outcomes.
Advanced Combination Therapies
The clinic uses a unique five-pillar treatment model. This includes bioimmunotherapy, surgery, minimally invasive therapy, radiotherapy, and integrated Chinese and Western medicine. For refractory or metastatic cancers, specialists pair immunotherapy with interventional therapy or local ablation. This method aims to activate the immune system while directly attacking the tumor mass.
Expert Medical Team
Dr. Luo Jiamin, the Deputy Director of the Oncology Ward, leads immunotherapy cases at the hospital. Dr. Luo Jiamin holds a Master’s degree in oncology and focuses on refractory tumors like lung, liver, and colorectal cancers. A multidisciplinary team (MDT) supports the treatment process. This team brings together experts in medical oncology, surgery, pathology, and imaging to build every patient's plan.
Specialized Hospital Facilities
Uni-Asia Cancer Hospital is a single-specialty facility focused on tumor therapy. The hospital treats around 20,000+ patients every year across two campuses. It features 600 beds and 80+ private hotel-standard rooms for patient comfort. The facility includes 12 dedicated departments to handle all aspects of cancer care and recovery.
You can request a consultation through Bookimed to learn more about immunotherapy options at this facility.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.